News
Los Angeles Times readers give their thoughts on Bill Plaschke's poignant column on Parkinson's disease, the Dodgers and the ...
Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...
Bill Plaschke, the award-winning sports columnist and longtime "Around the Horn" panelist, announced his Parkinson's ...
Morten Harket, the beloved front man of the pop-synth group A-ha, shared some heartbreaking health news with fans recently in ...
For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...
Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...
Parkinson's disease is a progressive and common neurodegenerative condition, typically characterized by involuntary shaking, ...
Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational ...
MJFF co-founder and CEO Deborah W. Brooks read a letter of gratitude from Michael J. Fox for the support of the mission from ...
Roche to advance prasinezumab into phase III development for early-stage Parkinson's disease: Basel Tuesday, June 17, 2025, 09:00 Hrs [IST] Roche announced its decision to proceed ...
New research links high consumption of ultra-processed foods to early signs of Parkinson’s disease, raising fresh concerns ...
20h
Zacks Investment Research on MSNRHHBY to Advance Parkinson's Disease Drug to Late-Stage DevelopmentRoche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results